Allegan Adds Device To Glaucoma Portfolio
This article was originally published in Clinica
Executive Summary
Allergan plc is diversifying its glaucoma drug portfolio with an agreement to buy AqueSys, Inc., a clinical-stage company developing a device to manage this ophthalmic condition.